US 9272990
Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
granted A61PA61P1/16A61P11/00
Quick answer
US patent 9272990 (Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis) held by AMIRA PHARMACEUTICALS, INC. expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AMIRA PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00